![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Gusella Milena Bononi Antonio Modena Yasmina Bertolaso Laura Franceschetti Paola Menon Daniela Pezzolo Elisa Barile Carmen Crepaldi Giorgio Bolzonella Caterina Inno Alessandro Padrini Roberto Pasini Felice
Publisher: Springer Publishing Company
ISSN: 0344-5704
Source: Cancer Chemotherapy and Pharmacology, Vol.73, Iss.3, 2014-03, pp. : 517-524
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Hjortsberg Catharina Persson Ulf Lidbrink Elisabet Bennett Charles
Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phase II clinical trial with pegylated liposomal doxorubicin
By Poveda A.
Sarcoma, Vol. 9, Iss. 3-4, 2005-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Harrington K.J. Lewanski C. Northcote A.D. Whittaker J. Peters A.M. Vile R.G. Stewart J.S.W.
European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. :